UB Paderborn / Katalog / Suche / in CDI

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

British journal of cancer, 2011-04, Vol.104 (9), p.1418-1425

2011

Volltextzugriff (PDF)

Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas

British journal of cancer, 2008-09, Vol.99 (5), p.768-773

2008

Volltextzugriff (PDF)

Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients

Archives of virology, 2006-10, Vol.151 (10), p.1899-1916

2006

Volltextzugriff (PDF)

HER‐2/neu overexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real‐time reverse transcription–polymerase chain reaction, and fluorescence in situ hybridization

International journal of gynecological cancer, 2008-01, Vol.18 (1), p.14-21

2008

Volltextzugriff (PDF)

Identification of stably expressed reference small non‐coding RNAs for microRNA quantification in high‐grade serous ovarian carcinoma tissues

Journal of cellular and molecular medicine, 2016-12, Vol.20 (12), p.2341-2348

2016

Volltextzugriff (PDF)

HER‐2/neu overexpression and amplification in uterine serous papillary carcinoma

International journal of gynecological cancer, 2008, Vol.18 (1), p.14-21

2008

Volltextzugriff (PDF)

0009: Extending the Platinum-Free Interval (PFI) with a Non-Platinum Therapy in Platinum (P)-Sensitive Recurrent Ovarian Cancer (Oc): Results From the Socrates Retrospective Study

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.601-601

2006

Volltextzugriff (PDF)

00086 ANALYSIS OF GENE EXPRESSION PATTERNS THAT DEFINES SEROUS PAPILLARY OVARIAN CARCINOMAS

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.75-75

2005

Volltextzugriff (PDF)

ANALYSIS OF GENE EXPRESSION PATTERNS THAT DEFINES SEROUS PAPILLARY OVARIAN CARCINOMAS: 00086

International journal of gynecological cancer, 2005-09, Vol.15 Suppl 2, p.75-75

2005

Volltextzugriff (PDF)

Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes

Frontiers in immunology, 2021-06, Vol.12, p.690201-690201

2021

Volltextzugriff (PDF)

Staging classification for cancer of the ovary, fallopian tube, and peritoneum

International journal of gynecology and obstetrics, 2014-01, Vol.124 (1), p.1-5

Prat, Jaime

2014

Volltextzugriff (PDF)

FIGO staging for carcinoma of the vulva, cervix, and corpus uteri

International journal of gynecology and obstetrics, 2014-05, Vol.125 (2), p.97-98

FIGO Committee on Gynecologic Oncology

2014

Volltextzugriff (PDF)

RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients

Scientific reports, 2017-09, Vol.7 (1), p.10528-10528, Article 10528

2017

Volltextzugriff (PDF)

Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients

Frontiers in oncology, 2020-09, Vol.10, p.584022-584022

2020

Volltextzugriff (PDF)

Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients

Gynecologic oncology, 2007-10, Vol.107 (1), p.S241-S247

2007

Volltextzugriff (PDF)

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis

BMC cancer, 2017-05, Vol.17 (1), p.366-366, Article 366

2017

Volltextzugriff (PDF)

OP19.02: Comparison of diagnostic performance between obstetric ultrasound and magnetic resonance imaging for antenatal diagnosis of placenta accreta spectrum disorders

Ultrasound in obstetrics & gynecology, 2019-10, Vol.54 (S1), p.148-148

2019

Volltextzugriff (PDF)

OP19.05: Concordance between obstetric ultrasound and magnetic resonance in antenatal diagnosis of placenta accreta spectrum disorders

Ultrasound in obstetrics & gynecology, 2019-10, Vol.54 (S1), p.149-149

2019

Volltextzugriff (PDF)

FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication

Journal of Gynecologic Oncology, 2015, 26(2), , pp.87-89

Prat, Jaime

2015

Volltextzugriff (PDF)

EP1159 Staging system comparison in vulvar squamous-cell cancer

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A602-A602

2019

Volltextzugriff (PDF)

EP1160 Prognostic factor in primary vulvar squamous-cell cancer in the context of FIGO 1988 and 2009 and Brigham and women's vulvar tumor classification system

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A602-A602

2019

Volltextzugriff (PDF)

Validation of an ERAS protocol in gynecological surgery: interim analysis of an italian randomized controlled trial

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A40-A40

2019

Volltextzugriff (PDF)

A clinical outcome-based prospective study on venous thromboembolism after cancer surgery : The @RISTOS project

Annals of surgery, 2006, Vol.243 (1), p.89-95

2006

Volltextzugriff (PDF)

PO-102: EGFR detection in saliva as an easy diagnostic and prognostic tool in oral squamous cell cancer

Radiotherapy and oncology, 2017-03, Vol.122, p.49-49

2017

Volltextzugriff (PDF)

EP520 Comparison of different preoperative biopsy techniques in endometrial cancer

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A320-A321

2019

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas

Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients

HER‐2/neu overexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real‐time reverse transcription–polymerase chain reaction, and fluorescence in situ hybridization

Identification of stably expressed reference small non‐coding RNAs for microRNA quantification in high‐grade serous ovarian carcinoma tissues

HER‐2/neu overexpression and amplification in uterine serous papillary carcinoma

0009: Extending the Platinum-Free Interval (PFI) with a Non-Platinum Therapy in Platinum (P)-Sensitive Recurrent Ovarian Cancer (Oc): Results From the Socrates Retrospective Study

00086 ANALYSIS OF GENE EXPRESSION PATTERNS THAT DEFINES SEROUS PAPILLARY OVARIAN CARCINOMAS

ANALYSIS OF GENE EXPRESSION PATTERNS THAT DEFINES SEROUS PAPILLARY OVARIAN CARCINOMAS: 00086

Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes

Staging classification for cancer of the ovary, fallopian tube, and peritoneum

FIGO staging for carcinoma of the vulva, cervix, and corpus uteri

RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients

Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients

Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis

OP19.02: Comparison of diagnostic performance between obstetric ultrasound and magnetic resonance imaging for antenatal diagnosis of placenta accreta spectrum disorders

OP19.05: Concordance between obstetric ultrasound and magnetic resonance in antenatal diagnosis of placenta accreta spectrum disorders

FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication

EP1159 Staging system comparison in vulvar squamous-cell cancer

EP1160 Prognostic factor in primary vulvar squamous-cell cancer in the context of FIGO 1988 and 2009 and Brigham and women's vulvar tumor classification system

Validation of an ERAS protocol in gynecological surgery: interim analysis of an italian randomized controlled trial

A clinical outcome-based prospective study on venous thromboembolism after cancer surgery : The @RISTOS project

PO-102: EGFR detection in saliva as an easy diagnostic and prognostic tool in oral squamous cell cancer

EP520 Comparison of different preoperative biopsy techniques in endometrial cancer

Suchergebnisse filtern